BioCentury
ARTICLE | Politics & Policy

Wyden introduces PBM transparency bill

March 15, 2017 11:13 PM UTC

A new U.S. Senate bill would require PBMs participating in Medicare to disclose the total amount of rebates and other discounts they receive from pharmaceutical companies, as well as the proportion of rebates that are passed on to health plans. The bill's sponsor, Sen. Ron Wyden (D-Ore.), said in a statement that the Creating Transparency to Have Drug Rebates Unlocked (C-THRU) Act is designed to reduce patient costs for prescription drugs and to "ensure people in Medicare receive a fair share of rebate savings."...